Theorem Clinical Research, Emergo Group Form Strategic Relationship

Theorem Clinical Research, Emergo Group Form Strategic Relationship

(King of Prussia, PA; July 9, 2013) Theorem Clinical Research and Emergo Group have formed a strategic relationship to provide global regulatory consulting services, including reimbursement consultation and in-country regulatory representation services, to the medical device and in vitro diagnostics community. 

"Emergo Group complements our own global strategic regulatory affairs and clinical trial capabilities," said D. Lee Spurgin Jr., Ph.D., Theorem senior vice president and general manager of medical device and diagnostic development. "Working together we can provide more services and a bigger global footprint, so our strategic relationship helps us to be a one-stop provider for our clients."

Emergo Group is a leading regulatory consultancy with more than 2,500 medical device and in vitro diagnostic device (IVD) clients and has offices offering a wide range of compliance and market access services in 25 countries. Emergo Group assists companies with global regulatory strategy, device registration, quality management system compliance, in-country regulatory representation and distributor qualification.

With offices in more than 30 countries worldwide, Theorem Clinical Research is a leading contract research organization specializing in the management of complex clinical trials for biopharmaceuticals, medical devices and drug-device combination products.

"The right strategic relationship strengthens both companies," said Emergo Group President and CEO Rene van de Zande. "We believe the synergy we achieve with Theorem is a benefit to all concerned."  

About Theorem Clinical Research

Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.

CONTACT:

Cindy Jacobus

Theorem Clinical Research

1.484.679.2400

[email protected]

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.